|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:1309-1316
© 2004 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Department of Surgery, Division of Cardiothoracic Surgery, Columbia University, College of Physicians and Surgeons, New York, NY, USA
b Department of Surgery, Division of Cardiac Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
Received for publication March 20, 2003; revisions received July 20, 2003; accepted for publication July 31, 2003.
* Address for reprints: Yoshifumi Naka, MD, PhD, Columbia University, College of Physicians and Surgeons, 177 Fort Washington Ave, Milstein Hospital 7GN-435, New York, NY 10032, USA
yn33{at}columbia.edu
OBJECTIVE: Implantation of a left ventricular assist device as a bridge to transplantation has become an acceptable approach for patients with end-stage heart failure. Our long-term results with 3 Thoratec HeartMate devices are presented to outline improvements in successful bridging to transplantation and post-transplant survival.
METHODS: From August 1990 through January 2003, 243 patients underwent implantation of Thoratec HeartMate devices as a bridge to transplantation. This included 52 (21.4%) pneumatic devices, 17 (7.0%) dual-lead vented electric devices, and 174 (71.6%) single-lead vented electric devices.
RESULTS: Mean age was 49.7 ± 13.7 years. Mean support time was 78.1 ± 82.9 days (0-541). Bridging success increased from 63.5% (n = 33) for pneumatic devices to 64.7% (n = 11) for dual-lead vented electric devices and 72.4% (n = 126) for single-lead vented electric devices (P = .005). Posttransplant 1-, 3-, and 5-year actuarial survival increased from 87.5%, 78.1%, and 71.9% in patients with pneumatic devices to 91.5%, 86.9%, and 81.3%, respectively, for patients with single-lead vented electric devices. Device infection and malfunction occurred in 17.7% (n = 43) and 12.8% (n = 31) of patients, respectively.
CONCLUSIONS: Successful bridging to transplantation and posttransplant survival has improved over time. Left ventricular assist devices have become increasingly more effective in bridging patients with end-stage heart failure to transplantation. This is likely due to a combination of better patient selection, improvements in clinical practice, and evolution in device design.
This article has been cited by other articles:
![]() |
M. Berman, J. Parameshwar, D. P. Jenkins, K. Dhital, C. Lewis, K. Dempster, P. Lincoln, C. Sudarshan, S. R. Large, J. Dunning, et al. Thoratec implantable ventricular assist device: The Papworth experience J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pal, V. Piacentino, A. D. Cuevas, T. Depp, M. A. Daneshmand, A. F. Hernandez, G. M. Felker, A. J. Lodge, J. G. Rogers, and C. A. Milano Impact of left ventricular assist device bridging on posttransplant outcomes. Ann. Thorac. Surg., November 1, 2009; 88(5): 1457 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Genovese, M. A. Dew, J. J. Teuteberg, M. A. Simon, J. Kay, M. P. Siegenthaler, J. K. Bhama, C. A. Bermudez, K. L. Lockard, S. Winowich, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann. Thorac. Surg., October 1, 2009; 88(4): 1162 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lietz, K. Brown, S. S. Ali, M. Colvin-Adams, A. J. Boyle, D. Anderson, A. D. Weinberg, L. W. Miller, S. Park, R. John, et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 1012 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ann. Thorac. Surg., October 1, 2008; 86(4): 1227 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Cleveland Jr., F. L. Grover, D. A. Fullerton, D. N. Campbell, M. B. Mitchell, J. Lindenfeld, E. E. Wolfel, B. D. Lowes, S. F. Shakar, A. Brieke, et al. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 774 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Osaki, N. M. Edwards, M. Velez, M. R. Johnson, M. A. Murray, J. A. Hoffmann, and T. Kohmoto Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experience. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 281 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kartha, W. Gomez, B. Wu, and K. Tremper Laparoscopic cholecystectomy in a patient with an implantable left ventricular assist device Br. J. Anaesth., May 1, 2008; 100(5): 652 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628. [Full Text] |
||||
![]() |
J. G. Rogers, J. Butler, S. L. Lansman, A. Gass, P. M. Portner, M. K. Pasque, R. N. Pierson III, and for the INTrEPID Investigators Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates: Results of the INTrEPID Trial J. Am. Coll. Cardiol., August 21, 2007; 50(8): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, K. Liao, K. Lietz, F. Kamdar, M. Colvin-Adams, A. Boyle, L. Miller, and L. Joyce Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haj-Yahia, E. J. Birks, P. Rogers, C. Bowles, M. Hipkins, R. George, M. Amrani, M. Petrou, J. Pepper, G. Dreyfus, et al. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 199 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Slaughter, S. S. Tsui, A. El-Banayosy, B. C. Sun, R. L. Kormos, D. K. Mueller, H. T. Massey, T. B. Icenogle, D. J. Farrar, J. D. Hill, et al. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1573 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chapman, J. Parameshwar, D. Jenkins, S. Large, and S. Tsui Psychosocial Issues for Patients with Ventricular Assist Devices: A Qualitative Pilot Study Am. J. Crit. Care., January 1, 2007; 16(1): 72 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Dang and Y. Naka Reply to the Editor J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1212 - 1212. [Full Text] [PDF] |
||||
![]() |
O. Ashraf Left ventricular assist device in heart failure J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1211 - 1212. [Full Text] [PDF] |
||||
![]() |
N. C. Dang, V. K. Topkara, B. T. Kim, M. L. Mercando, J. Kay, and Y. Naka Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1302 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Dang, V. K. Topkara, M. Leacche, R. John, J. G. Byrne, and Y. Naka Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 693 - 698. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |